GlassScriptPhysician profile
Mohan Kesani
NPI 1578513362
$15,750.78
in general payments reported to CMS, 2019-2025
60 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,106 · 2020: $819 · 2021: $2,392 · 2022: $2,537 · 2023: $3,428 · 2024: $2,040 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,787 · Travel and Lodging: $2,059 · Long Term Medical Supply Or Device Loan: $50.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,787.26 |
| Travel and Lodging | $2,058.95 |
| Long Term Medical Supply Or Device Loan | $50.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,412.50 | 2019-2025 | |
| Genentech USA, INC. | $2,062.33 | 2023 | |
| Janssen Pharmaceuticals, INC | $1,176.80 | 2019-2024 | Xarelto |
| Amgen INC. | $831.11 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $797.85 | 2019-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $736.25 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $674.77 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $619.57 | 2019-2024 | Farxiga, Breztri |
| E.R. Squibb & Sons, L.L.C. | $600.09 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $508.15 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $478.61 | 2019-2025 | Watchman Access System, Watchman Flx |
| Sanofi-Aventis U.S. LLC | $442.18 | 2019-2023 | |
| Medtronic, INC. | $336.76 | 2021-2024 | Micra |
| Kestra Medical Technology Services, INC. | $327.88 | 2022-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $263.06 | 2021-2025 | Uptravi, Opsumit |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $220.80 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Lilly USA, LLC | $209.83 | 2019-2024 | Jardiance |
| Abbott Laboratories | $208.02 | 2021-2025 | Coroflow, Cardiomems |
| Philips North America LLC | $179.33 | 2021-2024 | (Ck4) Mcot |
| Vifor Pharma, INC. | $169.02 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $164.49 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $152.53 | 2019-2020 | |
| Cook Medical LLC | $137.00 | 2022 | |
| Penumbra, INC. | $136.84 | 2023 | Penumbra System |
| Tactile Systems Technology INC | $126.99 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Alnylam Pharmaceuticals INC. | $125.47 | 2022-2025 | Onpattro, Amvuttra |
| Horizon Therapeutics Plc | $111.12 | 2019 | |
| Heartflow, INC. | $106.03 | 2024-2025 | |
| Lundbeck LLC | $101.25 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $101.19 | 2019-2025 | Evkeeza |
| Surmodics, INC. | $98.76 | 2025 | Pounce Venous Thrombectomy System, Pounce LP Thrombectomy, Pounce Xl Thrombectomy |
| Abbvie INC. | $98.24 | 2022 | |
| Nuwellis, INC. | $97.47 | 2024 | Aquadex Smartflow Console |
| Biotronik INC. | $97.04 | 2019 | |
| Medtronic Vascular, INC. | $93.91 | 2019-2020 | |
| Scpharmaceuticals INC. | $82.76 | 2023-2025 | |
| Baxter Healthcare | $79.07 | 2022-2025 | Hillrom - Eli 280 |
| Esperion Therapeutics, INC. | $78.11 | 2020-2024 | Nexletol |
| Edwards Lifesciences Corporation | $71.80 | 2019-2020 | |
| Cardiovascular Systems INC. | $65.38 | 2021-2023 | Diamondback Coronary |
| Pfizer INC. | $58.91 | 2021-2023 | |
| Astellas Pharma US INC | $44.92 | 2019-2025 | Veozah |
| Kiniksa Pharmaceuticals International, Plc | $44.53 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $34.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.32 | 2021 | |
| Amarin Pharma, INC. | $27.26 | 2019 | |
| Itamar Medical INC | $24.89 | 2023 | Watchpatone |
| Lantheus Medical Imaging, INC. | $22.95 | 2022 | |
| Cvrx, INC. | $22.55 | 2024 | Barostim Neo System |
| Kerecis Limited | $13.82 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $13.00 | 2025 | Rhythm Express |
| Arbor Pharmaceuticals, INC. | $12.40 | 2020 | |
| Siemens Medical Solutions USA, INC. | $11.88 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.54 | 2021 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$6,062.12 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Kesani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.